Annual Net Income
-$101.85 M
-$89.76 M-742.17%
31 December 2021
Summary:
Statera Biopharma annual net profit is currently -$101.85 million, with the most recent change of -$89.76 million (-742.17%) on 31 December 2021. During the last 3 years, it has fallen by -$89.76 million (-742.17%). STAB annual net income is now -3059.14% below its all-time high of -$3.22 million, reached on 31 December 2019.STAB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$3.35 M
+$138.60 K+3.97%
30 September 2022
Summary:
Statera Biopharma quarterly net profit is currently -$3.35 million, with the most recent change of +$138.60 thousand (+3.97%) on 30 September 2022. STAB quarterly net income is now -416.71% below its all-time high of -$648.10 thousand, reached on 01 March 2020.STAB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$91.83 M
+$9.37 M+9.26%
30 September 2022
Summary:
Statera Biopharma TTM net profit is currently -$91.83 million, with the most recent change of +$9.37 million (+9.26%) on 30 September 2022. STAB TTM net income is now -14069.51% below its all-time high of -$648.10 thousand, reached on 01 March 2020.STAB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
STAB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -742.2% | +73.7% | -218.4% |
| 5 y5 years | - | - | - |
STAB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -742.2% | at low | at high | +95.7% | -218.4% | +12.0% |
| 5 y | 5 years | -3059.1% | at low | -416.7% | +95.7% | <-9999.0% | +12.0% |
| alltime | all time | -3059.1% | at low | -416.7% | +95.7% | <-9999.0% | +12.0% |
Statera Biopharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$3.35 M(-4.0%) | -$91.83 M(-9.3%) |
| June 2022 | - | -$3.49 M(-55.0%) | -$101.20 M(-3.0%) |
| Mar 2022 | - | -$7.76 M(-90.0%) | -$104.32 M(+2.4%) |
| Dec 2021 | -$101.85 M | -$77.24 M(+507.2%) | -$101.85 M(+253.1%) |
| Sept 2021 | - | -$12.72 M(+92.6%) | -$28.84 M(+32.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$6.61 M(+24.9%) | -$21.80 M(+43.5%) |
| Mar 2021 | - | -$5.29 M(+25.0%) | -$15.20 M(+43.9%) |
| Dec 2020 | -$12.09 M(+275.1%) | -$4.23 M(-25.5%) | -$10.56 M(+66.9%) |
| Sept 2020 | - | -$5.68 M(+776.2%) | -$6.33 M(+876.2%) |
| Mar 2020 | - | -$648.10 K | -$648.10 K |
| Dec 2019 | -$3.22 M | - | - |
FAQ
- What is Statera Biopharma annual net profit?
- What is the all time high annual net income for Statera Biopharma?
- What is Statera Biopharma quarterly net profit?
- What is the all time high quarterly net income for Statera Biopharma?
- What is Statera Biopharma TTM net profit?
- What is the all time high TTM net income for Statera Biopharma?
What is Statera Biopharma annual net profit?
The current annual net income of STAB is -$101.85 M
What is the all time high annual net income for Statera Biopharma?
Statera Biopharma all-time high annual net profit is -$3.22 M
What is Statera Biopharma quarterly net profit?
The current quarterly net income of STAB is -$3.35 M
What is the all time high quarterly net income for Statera Biopharma?
Statera Biopharma all-time high quarterly net profit is -$648.10 K
What is Statera Biopharma TTM net profit?
The current TTM net income of STAB is -$91.83 M
What is the all time high TTM net income for Statera Biopharma?
Statera Biopharma all-time high TTM net profit is -$648.10 K